rs797044835
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001330311.2(DVL1):c.1594del(p.Trp532GlyfsTer142) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
DVL1
NM_001330311.2 frameshift
NM_001330311.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.36
Genes affected
DVL1 (HGNC:3084): (dishevelled segment polarity protein 1) DVL1, the human homolog of the Drosophila dishevelled gene (dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 is a candidate gene for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.237 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-1338096-CA-C is Pathogenic according to our data. Variant chr1-1338096-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 208045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-1338096-CA-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DVL1 | NM_001330311.2 | c.1594del | p.Trp532GlyfsTer142 | frameshift_variant | 14/15 | ENST00000378888.10 | NP_001317240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DVL1 | ENST00000378888.10 | c.1594del | p.Trp532GlyfsTer142 | frameshift_variant | 14/15 | 5 | NM_001330311.2 | ENSP00000368166 | P3 | |
DVL1 | ENST00000378891.9 | c.1519del | p.Trp507GlyfsTer142 | frameshift_variant | 14/15 | 1 | ENSP00000368169 | A1 | ||
DVL1 | ENST00000631679.1 | c.625del | p.Trp209GlyfsTer42 | frameshift_variant | 7/8 | 5 | ENSP00000488181 | |||
DVL1 | ENST00000632445.1 | c.523del | p.Trp175GlyfsTer42 | frameshift_variant | 4/6 | 5 | ENSP00000488888 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 38
GnomAD4 exome
Cov.:
38
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal dominant Robinow syndrome 2 Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Oct 02, 2021 | Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). The variant has been reported as pathogenic/likely pathogenic without evidence for the classification (ClinVar ID: VCV000504195.6). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | Sep 30, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 02, 2015 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2023 | Frameshift variant predicted to result in protein truncation, as the last 164 amino acids are replaced with 141 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging gain of function effect (Bunn et al., 2015); This variant is associated with the following publications: (PMID: 30266093, 25817016, 25817014, 32888393, 33237614, 35047859) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at